Frontiers reaches 6.4 on Journal Impact Factors
Frontiers in Cardiovascular Medicine is a global, peer-reviewed Open Access medical journal providing unrestricted, online access to publications on diagnostic and therapeutic advances in cardiology and cardiovascular disease. Frontiers in Cardiovascular Medicine publishes high quality peer-reviewed scientific investigations that are of relevance for the diagnosis, treatment, or pathogenesis of cardiovascular disease and related disorders with the goal to understand disease processes and to improve medical practice and patient care.
The Cardiovascular Metabolism section welcomes papers concerned with unravelling the roles of metabolic processes in cardiovascular homeostasis and the development of cardiovascular diseases. Recognizing that obesity is the major worldwide epidemic of the 21st century and cardiovascular disease is the predominant cause of mortality in obese individuals, our goal is to accelerate studies at the interface of cardiovascular and metabolic research disciplines. The Journal will consider papers that examine the effects of systemic metabolic dysfunction on the heart and vasculature, as well as the regulation of intermediary metabolic processes within the cells that these tissues encompass. Consideration will be given to studies that examine cardiovascular metabolism at all levels: from molecular biology and genetics, to morphological, biochemical, endocrine, pharmacological, and clinical studies.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, CrossRef, Semantic Scholar, Ulrich's Periodicals Directory, ESCI, CLOCKSS
PMCID: coming soon for all published articles
Cardiovascular Metabolism welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Correction, Editorial, General Commentary, Hypothesis and Theory, Mini Review, Opinion, Original Research, Perspective, Review and Systematic Review.
All manuscripts must be submitted directly to the section Cardiovascular Metabolism, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Cardiovascular Metabolism will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cardiovascular Medicine.